Alprolix Market Overview The Alprolix Market is experiencing significant growth driven by its innovative role in treating hemophilia B, a rare bleeding disorder. Alprolix, a recombinant factor IX product developed by Pfizer, offers extended half-life, which improves the management of bleeding episodes and reduces the frequency of injections for patients. The Alprolix Market Size was estimated...